FDA recall D-0653-2026

ACCORD BIOPHARMA INC · Class II · drug

Product

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.

Reason for recall

Lack of assurance of Sterility:

Distribution

US Nationwide.

Key facts

Status
Ongoing
Initiation date
2026-06-10
Report date
2026-07-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Raleigh, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0653-2026